Visit Rayner at ESCRS 2019 (booth F122)
Rayner will launch its RayOne Trifocal Toric fully preloaded IOL at the upcoming ESCRS 2019 congress in Paris on 14-18 September, completing its innovative family of trifocal IOLs.
With industry-leading 11% light loss from its patented diffractive design, RayOne Trifocal Toric will give cataract patients with varying degrees of preoperative corneal astigmatism the opportunity to become spectacle independent. RayOne Trifocal Toric complements RayOne Trifocal, launched at ESCRS 2017, which has since gained worldwide praise from surgeons for its predictive refractive outcomes combined with easy-to-use fully preloaded injector.
“At Rayner, we only focus on visual outcomes and aim to offer the best. Our trifocal technology has become the lens of choice for many surgeons thanks to its low light loss and reduced dysphotopsia. The missing piece of the jigsaw has been to have the same tried and tested technology for astigmatic patients. I’m thrilled that we will be launching RayOne Trifocal Toric at ESCRS 2019, completing our range of trifocal solutions and enabling surgeons to offer spectacle independence to more of their patients,” said Tim Clover, Rayner CEO.
Mr Allon Barsam, Medical Director and Founder of Ophthalmic Consultants of London (UK) implanted the world’s first RayOne Trifocal Toric on 15 July 2019. He states, “It is great to be the first centre in the world to implant Rayner’s latest high technology offering. Ethical innovation requires a careful balance ensuring patients have access to the latest and also safest technology once thorough R&D has been completed. Hugely grateful to be able to stand on the shoulders of giants and play a small role in this story.”
A multicentre pilot study across Japan, Germany and UK reports high patient satisfaction, spectacle independence at all distances and high cylinder reduction after the first week. The uncorrected distance visual acuity was reported as 0.00 ± 0.09, intermediate at -0.03 ± 0.05 and near at 0.05 ± 0.05. All surgeons involved in the study reported a high level of product satisfaction.
Mr Vinod Gangwani, Consultant Ophthalmic Surgeon at Ashford and St Peter's hospital NHS Foundation Trust (UK) said, “RayOne Trifocal Toric is preloaded in the best injector system and provides excellent vision at all distances. This lens completes the portfolio for my patients seeking spectacle independence.”
RayOne Trifocal Toric will be available to all countries that accept CE marking, plus Australia and Brazil, from 14 September 2019.
FURTHER INFORMATION
W: rayner.com/en/iol/multifocal/rayone-trifocal-toric
W: rayner.com/escrs-2019
